查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1372863

細胞隔離市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品、細胞類型、來源、技術、按應用、最終用戶、地區和競爭細分

Cell Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Cell Type, By Source, By Technique, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球細胞分離市場價值將於 2022 年達到 40.3 億美元，並有望實現顯著成長，預計到 2028 年年複合成長率 (CAGR) 為 13.04%。細胞分離，也稱為細胞分選，是一個過程從細胞群的異質混合物中辨識和分離特定細胞。這些目標細胞根據其細胞類型被分離和分離。細胞分離的常見方法包括磁力激活細胞分離、過濾、離心和流式細胞儀。

細胞分離在診斷疾病、進行細胞研究以及透過分析核糖核酸 (RNA) 表達來開發療法方面發揮關鍵作用。它簡化了細胞的實驗分析，並減少了樣本中其他細胞類型的干擾。因此，它在癌症研究、幹細胞生物學、免疫學和神經學等領域有著廣泛的應用。利用分離細胞的創新技術的一個例子是膜片鉗電生理學，它檢查帶電粒子穿過細胞膜的運動。分離的細胞在細胞培養中也很有用，其中單一細胞繁殖形成細胞集落。

此外，細胞分離具有多種治療應用。例如，可以分離、培養和移植胰島細胞來治療第 1 型糖尿病患者。

市場概況
預測期 2024-2028
2022 年市場規模 40.3億美元
2028 年市場規模 84.4億美元
2023-2028 年年複合成長率 13.04%
成長最快的細分市場 癌症研究
最大的市場 北美洲

主要市場促進因素

慢性病盛行率增加

糖尿病和癌症等慢性疾病的發生率不斷上升，導致對細胞療法的需求增加。此外，細胞分離在各種診斷實驗和慢性疾病研究中發揮著至關重要的作用。在藥物發現中，細胞分離對於研究細胞行為、疾病反應和藥物影響至關重要。細胞分離工具擴大應用於藥物發現技術中，以開發重組蛋白療法，用於治療多種疾病，包括癌症、自體免疫疾病和遺傳性疾病。慢性病的全球流行進一步擴大了分離的人體細胞在研究、藥物開發和臨床試驗中的應用。因此，在慢性病發病率不斷上升的推動下，對細胞療法的需求不斷成長，導致對細胞分離工具的需求不斷增加。

製藥和生物技術產業的研究活動迅速增加

細胞分離/細胞分離市場的強勁成長可歸因於製藥和生物技術產業內研究活動的顯著增加。這種激增是由於疾病數量的迅速增加以及發達的基礎設施和技術的進步而造成的。這些因素導致了對有效細胞分離和分離技術的需求，這進一步推動了市場的成長。

此外，對實驗室自動化不斷成長的需求也在促進細胞分離/細胞分離市場的成長中發揮了關鍵作用。隨著實驗室尋求簡化流程並提高效率，採用自動化解決方案進行細胞分離變得越來越重要。隨著越來越多的公司和研究機構認知到實驗室自動化在其科學工作中的好處和優勢，這反過來又推動了市場的擴張。許多生物技術公司，包括來自不已開發國家的公司，正在冒險進入這個市場。製藥公司可能會利用細胞分離技術來開發新藥物並促進創新。這些公司已經收購了重要的獨立單位來支持不斷擴大的幹細胞研究領域。生物技術和製藥公司產業預計將受到細胞分離技術推動的藥物和治療（例如 CAR-T）的進步的推動。目前，美國有 449 家上市生技公司，預計將推動生技和製藥公司的市場。

政府加強生物醫學研究活動的政策

近年來，世界各國政府為支持和促進生物醫學研究活動而實施的措施和政策顯著增加。這主要是由於客戶對此類研究重要性的認知不斷提高，以及人口老化和慢性病盛行率上升。因此，細胞隔離市場經歷了快速成長的軌跡。

生物技術領域的大量投資和醫療保健基礎設施的不斷改善預計將進一步刺激細胞分離市場的擴張。這些投資和進步不僅有助於市場的整體成長，而且促進了細胞分離領域的創新和技術進步。

隨著老年人口的成長，對臨床試驗和研究的需求也增加

與年輕人相比，65 歲及以上的老年族群更容易罹患癌症和神經系統疾病等慢性疾病。值得注意的是，老年人口正在經歷快速成長，這進一步放大了解決這些健康問題的重要性。隨著 65 歲及以上人口數量的不斷增加，阿茲海默症、失智症、癌症和免疫性疾病等疾病的盛行率預計將顯著上升。

因此，針對這些情況的矯正治療的需求將會不斷增加。預計這種需求激增也將擴展到細胞分離產品領域，該產品在包括臨床試驗在內的各種研究工作中發揮著至關重要的作用。因此，在這些因素的推動下，全球細胞分離技術市場預計將大幅成長。

主要市場挑戰

缺乏技術熟練的個人

該領域技術熟練的工人短缺，加上人們越來越擔心細胞分離程序存在嚴格的規則和合規性，預計將限制整體市場的擴張。此外，與細胞分離技術植入治療相關的高成本可能對未來幾年市場的成長構成重大威脅。這些因素突顯出需要採取策略措施和創新解決方案來克服這些挑戰並促進永續的市場成長。

從實驗室診斷轉向家庭測試

在客戶意識增強的推動下，從實驗室診斷轉向家庭測試，導致併發症發生的可能性降低，技術也取得了顯著進展。因此，細胞分離/細胞分離市場的成長預計將放緩。此外，與服務合約和原料相關的高成本可能會阻礙市場成長。這些因素共同導致了細胞隔離市場面臨的挑戰，強調需要策略解決方案來解決這些問題並確保產業的持續成長。

主要市場趨勢

技術進步

預計細胞分離技術市場在未來幾年將經歷顯著的成長機會。這可以歸因於基於細胞的技術的快速進步，例如更高的純度產量和更少的細胞分離時間。此外，政府為改進細胞技術和細胞分離技術的成本效益而採取的措施的增加預計將有助於市場成長。此外，發展中國家發達的醫療基礎設施為細胞分離技術的採用和實施提供了有利的環境。所有這些因素結合在一起，使得細胞分離技術市場在可預見的未來將大幅擴張。

產品創新

產品供應的進步推動了全球細胞分離市場的成長。該市場的產品創新主要是由各種慢性和傳染病的細胞研究中對自動化工具不斷成長的需求所推動的。 BD 和 QIAGEN 等市場主要參與者致力於持續改進產品。例如，2019 年3 月，BD 推出了BD FACSDuet 自動流式細胞儀系統，這是一種全自動樣品製備儀器，可在BD FACSLyric 臨床流程上運行檢測時最大限度地減少錯誤並減少手動用戶交互的需要，從而提高臨床實驗室的效率細胞儀。其他供應商，如 Bio-Rad，則專注於流式細胞儀試劑的開發。 2020 年 11 月，Bio-Rad Laboratories, Inc. 推出了 StarBright Blue 700、StarBright Violet 440 和 StarBright Violet 610 染料，為流式細胞儀提供最大亮度和更高的解析度。因此，成熟市場參與者不斷改進產品推動了市場成長並有助於增加這些產品的銷售量。

細分市場洞察

細胞類型見解

根據細胞類型，市場分為人類細胞和動物細胞。 2022年，人類細胞類別在收入佔有率方面成為領先者。這可以歸因於人們對癌症和人類研究的日益重視，以及分離的人類細胞在生物製藥開發、臨床試驗和研究中的廣泛應用。此外，工業化國家對個人化醫療有吸引力的支付政策進一步促進了對人體細胞分離的需求。預計動物細胞領域在預測期內也將獲利成長。新藥的開發引起了政府機構、商業部門和醫療機構的高度關注，從而推動了該領域的成長。動物細胞在新藥的發現和開發中發揮著至關重要的作用，能夠評估毒性、藥物動力學和有效性。

技術見解

根據技術領域，市場分為基於離心的細胞分離、基於表面標記的細胞分離和基於過濾的細胞分離。基於離心的細胞分離細分市場在 2022 年佔據最大的收入佔有率，一直是細胞分離市場的主導力量。該技術被學術機構、研究中心和生物技術/生物製藥公司廣泛使用。離心在細胞分離中起著至關重要的作用，常用的差速離心和密度梯度離心。密度梯度離心利用分子量進行顆粒分離，而差速離心則利用裂解物破壞細胞膜。

展望未來，表面標記和過濾領域預計將顯著成長。這一市場擴張主要是由產品開發和企業對製造基礎設施投資的增加所推動的。製造商在生產和研究過程中利用創新的表面標記和過濾系統來提高最終產品的品質。

區域洞察

在慢性病盛行率不斷上升、個人化醫療需求不斷成長以及政府對細胞研究和開發的資助的推動下，北美市場預計將在未來幾年引領全球細胞分離產業。憑藉其先進的醫療保健系統、強大的研發部門以及對生物技術研究的不斷增加的投資，北美地區預計將出現最顯著的收入成長。

由於醫療成本不斷上升、患者群體龐大以及對尖端細胞分離方法的興趣日益濃厚等因素，預計亞太地區的細胞分離市場將快速擴張。該地區擁有多個新興國家，包括中國和印度，這些國家的慢性病發病率正在上升。此外，技術人員的可及性和可承受的生產成本預計將吸引細胞分離產業的眾多主要參與者來到該地區。

在政府生命科學研究和開發支出增加以及慢性疾病流行等因素的推動下，歐洲市場預計將呈現溫和成長。 Thermo Fisher Scientific、STEMCELL Technologies 和 Merck KGaA 等細胞分離市場的主要參與者都是該地區的知名公司。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球細胞隔離市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（消耗品和儀器）
    • 依細胞類型（人類細胞和動物細胞）
    • 依來源分類（骨髓、臍帶血/胚胎幹細胞、脂肪組織）
    • 依技術分類（基於離心的細胞分離、基於表面標記的細胞分離、基於過濾的細胞分離）
    • 按應用（生物分子分離、癌症研究、幹細胞研究、體外診斷、其他）
    • 按最終用戶（生物技術和生物製藥公司、研究實驗室和研究所、醫院和診斷實驗室、細胞庫）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美細胞隔離市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按細胞類型
    • 按來源
    • 依技術
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲細胞隔離市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按細胞類型
    • 按來源
    • 依技術
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區細胞隔離市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按細胞類型
    • 按來源
    • 依技術
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲細胞隔離市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按細胞類型
    • 按來源
    • 依技術
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲細胞隔離市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按細胞類型
    • 按來源
    • 依技術
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非細胞分離
    • 沙烏地阿拉伯細胞分離
    • 阿拉伯聯合大公國細胞分離

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球細胞隔離市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Becton, Dickinson & Company
    • Merck KGaA (Millipore Sigma)
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories Inc.
    • Terumo Corporation
    • PluriSelect Life Science UG & Co. KG
    • Danaher Corporation (Cytiva)
    • STEMCELL Technologies Inc.
    • Corning Inc.
    • Akadeum Life Sciences Inc.

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 5108

The Global Cell Isolation Market reached a value of USD 4.03 Billion in 2022 and is poised for remarkable growth, with an expected Compound Annual Growth Rate (CAGR) of 13.04% through 2028. Cell isolation, also known as cell sorting, is the process of identifying and separating specific cells from a heterogeneous mixture of cell populations. These targeted cells are isolated and separated based on their cell type. Common methods for cell isolation include magnet-activated cell isolation, filtration, centrifugation, and flow cytometry.

Cell isolation plays a pivotal role in diagnosing diseases, conducting cellular research, and developing therapies by analyzing ribonucleic acid (RNA) expressions. It simplifies the experimental analysis of cells and reduces interference from other cell types within the sample. Consequently, it finds extensive applications in fields such as cancer research, stem cell biology, immunology, and neurology. An example of an innovative technique that utilizes isolated cells is patch-clamp electrophysiology, which examines the movement of charged particles across the cell membrane. Isolated cells are also instrumental in cell culture, where a single cell multiplies to form a colony of cells.

Moreover, cell isolation has various therapeutic applications. For instance, pancreatic islet cells can be isolated, cultured, and transplanted to treat patients with Type 1 Diabetes.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 4.03 Billion
Market Size 2028USD 8.44 Billion
CAGR 2023-202813.04%
Fastest Growing SegmentCancer Research
Largest MarketNorth America

Key Market Drivers

Increasing Prevalence of Chronic Diseases

The growing incidence of chronic diseases, such as diabetes and cancer, has led to an increased demand for cell-based therapies. Additionally, cell isolation plays a crucial role in various diagnostic experiments and research on chronic diseases. In drug discovery, cell isolation is essential for studying cellular behavior, disease response, and drug impact. Cell isolation tools are increasingly utilized in drug discovery techniques to develop recombinant protein therapeutics for treating a wide range of diseases, including cancer, autoimmune disorders, and genetic conditions. The global prevalence of chronic diseases has further amplified the applications of isolated human cells in research, drug development, and clinical trials. Therefore, the rising demand for cell-based therapies, driven by the growing incidence of chronic diseases, has resulted in an increased need for cell isolation tools.

The growth of chronic diseases, such as diabetes, obesity, arthritis, heart disorders, and cancer, is influenced by factors like increased sedentary lifestyle, global population aging, and higher rates of cigarette smoking and alcohol consumption. According to Imperial College London, chronic illnesses were projected to account for over 70% of global fatalities in 2020, with more than 41 million deaths annually. Approximately 17 million of these deaths are considered premature, occurring at a younger age than expected.

Consequently, the demand for cellular therapies to address chronic diseases is escalating alongside the burden of these conditions. This has led to increased focus and funding in research to develop effective remedies. As a result, the global market for cell isolation technologies is being driven by the growing activities in cellular research.

Rapid Increase in The Research Activities In The Pharmaceutical And Biotechnological Industries

The robust growth of the Cell Isolation/Cell isolation Market can be attributed to the significant increase in research activities within the pharmaceutical and biotechnological industries. This surge is in response to the rapid rise in the number of diseases, as well as the presence of well-developed infrastructures and advancements in technology. These factors contribute to the need for effective cell isolation and separation techniques, which further drives the market growth.

Moreover, the growing demand for laboratory automation has also played a pivotal role in enhancing the growth of the Cell Isolation/Cell isolation Market. As laboratories seek to streamline their processes and improve efficiency, the adoption of automated solutions for cell isolation and separation becomes increasingly important. This, in turn, fuels the expansion of the market, as more companies and research institutions recognize the benefits and advantages of laboratory automation in their scientific endeavors. Numerous biotechnology companies, including those from underdeveloped nations, are venturing into the market. Pharmaceutical corporations are likely to utilize cell isolation techniques to develop new medications and foster innovation. These companies have acquired significant independent units to support the expanding stem cell research field. The biotechnology and pharmaceutical firms' sector is expected to be propelled by the advancements in medications and treatments, such as CAR-T, facilitated by cell isolation technologies. Currently, there are 449 public biotech companies operating in the U.S., which is anticipated to drive the market for biotechnology and pharmaceutical companies.

Government's Policies to Enhance Biomedical Research Activities

In recent years, there has been a remarkable surge in initiatives and policies implemented by governments worldwide to support and promote biomedical research activities. This is primarily driven by the increasing awareness among customers about the significance of such research, as well as the growing number of aging population and the rising prevalence of chronic diseases. Consequently, the Cell Isolation Market has experienced a rapid growth trajectory.

Substantial investments in the biotechnology sector and continuous improvements in the healthcare infrastructure are expected to further stimulate the expansion of the Cell Isolation Market. These investments and advancements not only contribute to the overall growth of the market but also foster innovation and technological advancements in the field of cell isolation and separation.

Demand For Clinical Trials and Research Is Increasing As The Geriatric Population Grows

The senior population, comprising individuals aged 65 and over, is more prone to chronic illnesses such as cancer and neurological disorders when compared to the younger population. Notably, the geriatric population is experiencing rapid growth, which further magnifies the significance of addressing these health concerns. With the increasing number of individuals aged 65 and over, the prevalence of conditions like Alzheimer's, dementia, cancer, and immunological illnesses is expected to rise significantly.

Consequently, there will be an escalating demand for corrective treatments to cater to these conditions. This surge in demand is also projected to extend to the field of cell isolation products, which play a crucial role in various research endeavors, including clinical trials. As a result, the global market for cell isolation technologies is anticipated to witness substantial growth, driven by these factors.

Key Market Challenges

Lack of Technically Skilled Individuals

The shortage of technically competent workers in the field, coupled with the increasing concerns about the existence of tight rules and compliances for cell separation procedures, are projected to restrain the overall market expansion. Moreover, the high cost associated with cell separation technology implant treatments can potentially pose a significant threat to the growth of the market in the coming years. These factors highlight the need for strategic measures and innovative solutions to overcome these challenges and foster sustainable market growth.

Shift From Lab-Based Diagnosis to Home-Based Testing

The shift from lab-based diagnosis to home-based testing, driven by increased customer awareness, has led to a decrease in the chances of complications and significant advancements in technology. As a result, the growth of the Cell Isolation/Cell Separation Market is anticipated to be reduced. Additionally, the market growth may be hampered by the high costs associated with service contracts and raw materials. These factors collectively contribute to the challenges faced by the Cell Isolation Market, emphasizing the need for strategic solutions to address these concerns and ensure sustained growth in the industry.

Key Market Trends

Technological Advancement

It is anticipated that the cell separation technology market will experience significant growth opportunities in the coming years. This can be attributed to the rapid technological advancements in cell-based technology, such as higher purity yield and reduced cell isolation time. Additionally, the rise in government initiatives to improve cell-based technology and the cost-effectiveness of cell separation techniques are expected to contribute to market growth. Furthermore, the well-developed healthcare infrastructure in developing countries provides a favorable environment for the adoption and implementation of cell separation technologies. All these factors combined make the cell separation technology market poised for substantial expansion in the foreseeable future.

Product Innovations

The growth of the global cell isolation market is being fueled by advancements in the product offerings. Product innovations in this market are primarily driven by the increasing demand for automated tools in cell-based research for various chronic and infectious diseases. Key players in the market, such as BD and QIAGEN, are dedicated to continuous product improvement. For instance, in March 2019, BD introduced the BD FACSDuet automated flow cytometry system, a fully automated sample preparation instrument that enhances the efficiency of clinical laboratories by minimizing errors and reducing the need for manual user interactions when running assays on the BD FACSLyric clinical flow cytometer. Other vendors, like Bio-Rad, are focused on the development of reagents for flow cytometry. In November 2020, Bio-Rad Laboratories, Inc. launched StarBright Blue 700, StarBright Violet 440, and StarBright Violet 610 dyes, which provide maximum brightness and improved resolution for flow cytometry. Hence, the continuous product advancements by established market players drive market growth and contribute to increased sales of these products.

Segmental Insights

Cell Type Insights

Based on the cell type, the market is segmented into human cells and animal cells. In 2022, the human cell category emerged as the leader in terms of revenue share. This can be attributed to the growing emphasis on cancer and human research, as well as the wide range of applications of isolated human cells in biopharmaceutical development, clinical trials, and research. Moreover, the attractive payment policies for personalized medicine in industrialized countries further contribute to the demand for human cell isolation. It is projected that the animal cells segment will also witness profitable growth during the forecast period. The development of novel drugs has garnered significant attention from government bodies, the commercial sector, and healthcare organizations, thereby driving the growth of this segment. Animal cells play a crucial role in the discovery and development of new drugs, enabling the assessment of toxicity, pharmacokinetics, and effectiveness.

Technique Insights

Based on the technique segment, the market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. The centrifugation-based cell isolation segment, accounted for the largest revenue share in 2022, has been a dominant force in the cell separation market. This technique is widely utilized by academic institutions, research centers, and biotechnology/biopharmaceutical companies. Centrifugation plays a crucial role in cell isolation, with both differential centrifugation and density gradient centrifugation commonly employed. Density gradient centrifugation leverages molecular weights for particle separation, while differential centrifugation employs lysates to disrupt cell membranes.

Looking ahead, significant growth is expected in both the surface marking and filtration segments. This market expansion is primarily driven by product development and increased corporate investments in manufacturing infrastructure. Manufacturers utilize innovative surface markers and filtration systems in their production and research processes to enhance the quality of the final product.

Regional Insights

The North American market is poised to lead the global cell isolation industry in the coming years, driven by the increasing prevalence of chronic diseases, growing demand for personalized medicine, and government funding for cell-based research and development. With its advanced healthcare system, robust research and development sector, and increasing investment in biotechnology research, North America is expected to witness the most significant revenue growth.

Asia Pacific is anticipated to experience rapid expansion in the cell isolation market due to factors such as escalating healthcare costs, a large patient base, and growing interest in cutting-edge cell separation methods. The region boasts several emerging nations, including China and India, where the incidence of chronic diseases is on the rise. Additionally, the accessibility to skilled personnel and affordable production costs is expected to attract numerous major players in the cell isolation industry to the region.

The European market is projected to exhibit moderate growth, driven by factors such as increased government spending on life sciences research and development and the prevalence of chronic disorders. Key players in the cell isolation market, such as Thermo Fisher Scientific, STEMCELL Technologies, and Merck KGaA, are among the notable companies based in the region.

Key Market Players

  • Becton, Dickinson & Company
  • Merck KGaA (Millipore Sigma)
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Terumo Corporation
  • PluriSelect Life Science UG & Co. KG
  • Danaher Corporation (Cytiva)
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences Inc.

Report Scope:

In this report, the Global Cell Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Isolation Market, By Product:

  • Consumables
  • Instruments

Cell Isolation Market, By Cell Type:

  • Human Cells
  • Animal Cells

Cell Isolation Market, By Source:

  • Bone Marrow
  • Cord Blood/Embryonic Stem Cells
  • Adipose Tissue

Cell Isolation Market, By Technique:

  • Centrifugation-Based Cell Isolation
  • Surface Marker-Based Cell Isolation
  • Filtration-Based Cell

Cell Isolation Market, By Application:

  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • In Vitro Diagnostic
  • Others

Cell Isolation Market, By End User:

  • Biotechnology and Biopharmaceutical Companies
  • Research Laboratories and Institutes
  • Hospitals and Diagnostic Laboratories
  • Cell Banks

Cell Isolation Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Cell Isolation Market.

Available Customizations:

  • Global Cell Isolation market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Isolation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables and Instruments)
    • 5.2.2. By Cell Type (Human Cells and Animal Cells)
    • 5.2.3. By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue)
    • 5.2.4. By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation)
    • 5.2.5. By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others)
    • 5.2.6. By End User (Biotechnology and Biopharmaceutical Companies, Research Laboratories and Institutes, Hospitals and Diagnostic Laboratories, Cell Banks)
    • 5.2.7. By Region
    • 5.2.8. By Company (2022)
  • 5.3. Market Map

6. North America Cell Isolation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Cell Type
    • 6.2.3. By Source
    • 6.2.4. By Technique
    • 6.2.5. By Application
    • 6.2.6. By End User
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Isolation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Cell Type
        • 6.3.1.2.3. By Source
        • 6.3.1.2.4. By Technique
        • 6.3.1.2.5. By Application
        • 6.3.1.2.6. By End User
    • 6.3.2. Canada Cell Isolation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Cell Type
        • 6.3.2.2.3. By Source
        • 6.3.2.2.4. By Technique
        • 6.3.2.2.5. By Application
        • 6.3.2.2.6. By End User
    • 6.3.3. Mexico Cell Isolation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Cell Type
        • 6.3.3.2.3. By Source
        • 6.3.3.2.4. By Technique
        • 6.3.3.2.5. By Application
        • 6.3.3.2.6. By End User

7. Europe Cell Isolation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Cell Type
    • 7.2.3. By Source
    • 7.2.4. By Technique
    • 7.2.5. By Application
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cell Isolation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Cell Type
        • 7.3.1.2.3. By Source
        • 7.3.1.2.4. By Technique
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By End User
        • 7.3.1.2.7.
    • 7.3.2. United Kingdom Cell Isolation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Cell Type
        • 7.3.2.2.3. By Source
        • 7.3.2.2.4. By Technique
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By End User
    • 7.3.3. Italy Cell Isolation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Cell Type
        • 7.3.3.2.3. By Source
        • 7.3.3.2.4. By Technique
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By End User
    • 7.3.4. France Cell Isolation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Cell Type
        • 7.3.4.2.3. By Source
        • 7.3.4.2.4. By Technique
        • 7.3.4.2.5. By Application
        • 7.3.4.2.6. By End User
    • 7.3.5. Spain Cell Isolation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Cell Type
        • 7.3.5.2.3. By Source
        • 7.3.5.2.4. By Technique
        • 7.3.5.2.5. By Application
        • 7.3.5.2.6. By End User

8. Asia-Pacific Cell Isolation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Cell Type
    • 8.2.3. By Source
    • 8.2.4. By Technique
    • 8.2.5. By Application
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Cell Isolation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Cell Type
        • 8.3.1.2.3. By Source
        • 8.3.1.2.4. By Technique
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By End User
    • 8.3.2. India Cell Isolation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Cell Type
        • 8.3.2.2.3. By Source
        • 8.3.2.2.4. By Technique
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By End User
    • 8.3.3. Japan Cell Isolation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Cell Type
        • 8.3.3.2.3. By Source
        • 8.3.3.2.4. By Technique
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By End User
    • 8.3.4. South Korea Cell Isolation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Cell Type
        • 8.3.4.2.3. By Source
        • 8.3.4.2.4. By Technique
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By End User
    • 8.3.5. Australia Cell Isolation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Cell Type
        • 8.3.5.2.3. By Source
        • 8.3.5.2.4. By Technique
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By End User

9. South America Cell Isolation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Cell Type
    • 9.2.3. By Source
    • 9.2.4. By Technique
    • 9.2.5. By Application
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cell Isolation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Cell Type
        • 9.3.1.2.3. By Source
        • 9.3.1.2.4. By Technique
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By End User
    • 9.3.2. Argentina Cell Isolation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Cell Type
        • 9.3.2.2.3. By Source
        • 9.3.2.2.4. By Technique
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By End User
    • 9.3.3. Colombia Cell Isolation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Cell Type
        • 9.3.3.2.3. By Source
        • 9.3.3.2.4. By Technique
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By End User

10. Middle East and Africa Cell Isolation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Cell Type
    • 10.2.3. By Source
    • 10.2.4. By Technique
    • 10.2.5. By Application
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cell Isolation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Cell Type
        • 10.3.1.2.3. By Source
        • 10.3.1.2.4. By Technique
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By End User
    • 10.3.2. Saudi Arabia Cell Isolation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Cell Type
        • 10.3.2.2.3. By Source
        • 10.3.2.2.4. By Technique
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By End User
    • 10.3.3. UAE Cell Isolation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Cell Type
        • 10.3.3.2.3. By Source
        • 10.3.3.2.4. By Technique
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Cell Isolation Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Becton, Dickinson & Company
    • 15.5.2. Merck KGaA (Millipore Sigma)
    • 15.5.3. Thermo Fisher Scientific Inc.
    • 15.5.4. Bio-Rad Laboratories Inc.
    • 15.5.5. Terumo Corporation
    • 15.5.6. PluriSelect Life Science UG & Co. KG
    • 15.5.7. Danaher Corporation (Cytiva)
    • 15.5.8. STEMCELL Technologies Inc.
    • 15.5.9. Corning Inc.
    • 15.5.10. Akadeum Life Sciences Inc.

16. Strategic Recommendations

17. About Us & Disclaimer